Site-specific TREM2 fragment ratios (N-terminal vs. C-terminal) distinguish homeostatic from priming-phase microglia. Reflects TREM2 shedding by ADAM10/17 proteases, which is regulated by microglial activation state. Direct mechanistic linkage to TREM2 biology enables alignment with active TREM2-targeted therapeutic programs, though the required mass spectrometry assay does not yet exist.
A weighted combinatorial algorithm combining a priming-associated marker (YKL-40), a microglial activation state marker (sTREM2), and a synaptic vulnerability marker (neurogranin) creates a composite fingerprint for identifying the temporal window before neurodegeneration. The multi-marker approach provides statistical robustness against individual marker limitations, though it inherits component weaknesses and carries overfitting risk requiring rigorous external validation.
Verdict Summary
5/10
dimensions won
CSF Soluble TREM2 Fragment Ratio as Prim
6/10
dimensions won
Integrated Multi-Analyte CSF Panel Combi
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.65
Evidence
0.58
0.68
Novelty
0.72
0.65
Feasibility
0.55
0.82
Impact
0.82
0.78
Druggability
0.88
0.70
Safety
0.85
0.85
Competition
0.70
0.72
Data
0.50
0.80
Reproducible
0.52
0.65
Score Breakdown
Dimension
CSF Soluble TREM2 Fragment Rat
Integrated Multi-Analyte CSF P
Mechanistic
0.700
0.650
Evidence
0.580
0.680
Novelty
0.720
0.650
Feasibility
0.550
0.820
Impact
0.820
0.780
Druggability
0.880
0.700
Safety
0.850
0.850
Competition
0.700
0.720
Data
0.500
0.800
Reproducible
0.520
0.650
Evidence
CSF Soluble TREM2 Fragment Ratio as Priming State Indicator
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...